A Phase IV Study to Assess the Safety of EupentaTM Inj
Last updated on July 2021Recruitment
- Recruitment Status
- Not yet recruiting
- Estimated Enrollment
- Same as current
Summary
- Conditions
- Diphtheria
- Haemophilus Influenzae Type b Infection
- Hepatitis B
- Pertussis
- Tetanus
- Type
- Interventional
- Phase
- Phase 4
- Design
- Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Prevention
Participation Requirements
- Age
- Younger than 68 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT04056728
- Collaborators
- Not Provided
- Investigators
- Not Provided